Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Aclara Reports Receding Revenue, Narrowed Loss in Q1

NEW YORK, April 30 - Aclara today reported significantly receded revenue, a decrease in operating spending, and a narrowed net loss.

 

Total revenue for the quarter ended March 31 was $590,000 compared with $934,000 in the year-ago period, Aclara said.

 

Operating expenses in the period were $10.8 million, down from $13.4 million Aclara reported for the first quarter 2001. R&D spending grew to $6.2 million in the current quarter from $5.2 million year over year.

 

Net loss narrowed to $9.1 million, or $.25 per share, from $9.8 million, or $.28 per share one year ago.

 

Aclara said it had just under $17 million in cash and cash equivalents as of March 31.

 

For more information, click here.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.